A new study published in the New England Journal of Medicine found that the 13-valent polysaccharide conjugate vaccine (Pfizer s Prevnar 13/PCV13) was effective in protecting seniors from the strains of pneumococcus (a bacterium that causes infections
Yesterday we discussed the remarkable efficacy of routine vaccines against previously dangerous infections, particularly measles, and what happens when parents fail to vaccinate their children.